Abstract Ziv‐aflibercept (Zaltrap®), a recombinant fusion protein that binds diffusible
vascular endothelial growth factor (VEGF), is approved for the treatment of metastatic …

Collaborative research has become a viable and strategic engagement for universities and
scholars. Researchers often take part in grants and share scarce resources while gaining …

Purpose Delivering ophthalmic drugs to the target tissues in eye is challenging due to
transport barriers. Rapid tear clearance of the drug instilled as eye drops to treat anterior …

There are many factors that have been observed to attract more citations. One of the most
popular factors is number of authors, often positively associated with an increase in citations …

Objective The purpose of this study is to determine if ziv-aflibercept is a safe and effective
maintenance drug for nAMD. Study Design and Methods This is a randomized, prospective …

Background Diabetic macular edema (DME) is a leading cause of visual loss in diabetic
patients and is managed using multiple anti-vascular endothelial growth factor (VEGF) …

Abstracts Well-designed prospective randomized controlled clinical trials of choroidal
neovascularization secondary to age-related macular degeneration (CNV-AMD) have not …

The progressive aging of the population has led to an increase in the number of chronic
diseases. Age-related macular degeneration (AMD) is the leading cause of permanent …